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Abstract
We describe a 41-year-old African-American male who initially presented in respiratory distress. He
had a positive history of asthma, cigarette smoking, and only recent possible asbestos exposure six
months prior to onset of symptoms. Mesothelioma was suspected after chest radiography and
PET-CT, and confirmed by immunohistochemical tissue analysis. We postulate that immunosuppres-
sion enhances susceptibility to mesothelioma, since weakened immune systems are present in both
HIV/AIDS patients like this 41-year-old man, and elderly patients who compose the population that
classically presents with mesothelioma. Furthermore, immunosuppression may be a prerequisite to
the development of mesothelioma.
Introduction
Mesothelioma is a type of cancer that affects the serous
lining of the thorax, abdomen, or pelvis. Its incidence is 1
per 100 000 persons in the United States, and the 5-year
survival is 3%. Mesothelioma classically occurs after the 5
th
decade of life in individuals with a history of significant
asbestos exposure that predates the cancer by 30-50 years.
Disease risk is proportional to duration and dose of
asbestos exposure. Initial clinical symptoms include
shortness of breath and pleuritic chest pain, and imaging
studiesmay reveal pleural/peritonealeffusions. Thelifetime
risk of developing mesothelioma after asbestos exposure is
approximately 10%, however roughly 30% of mesothe-
lioma victims do not have a history of asbestos exposure
[1]. There does not appear to be a direct association
between cigarette smoking and mesothelioma. This report
describes advanced mesothelioma in a man who was
relatively young and without significant asbestos exposure.
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The 41-year-old African-American man presented to the
Emergency Department with severe shortness of breath, as
well as severe, sharp, intermittent right-sided chest pain for
2-days duration without radiation. He had a history of
asthma and HIV with progression to AIDS in the past 3
years. He also had a history of chronic alcohol and illicit
drug use, and 20-pack years of cigarette smoking. Over the
past 30-years, he worked in housekeeping at various hotels
and occasionally as a shoe shiner. He did not have any
occupational history of mining/milling, construction, ship-
yard work or plumbing. The patient did have a brief history
of assisting to demolish a house over an 8-hour period
approximately 1 year previously; however it was unclear
whether there was asbestos exposure during that time.
Physical examination revealed an anxious man in
severe respiratory distress. His blood pressure was 157/
86 mmHg; pulse rate 120/min; respiratory rate 40/min;
temperature 97°F and oxygen saturation 92% on room
air. He had reduced breath sounds throughout the left
lung fields, with crackles in the right lower lung fields. The
trachea was midline. He was tachycardic withnormal heart
sounds and a soft systolic murmur at the left lower sternal
border. His abdomen was soft and without distention,
tenderness or organomegaly. Capillary refill was normal,
and Homan’s sign was negative. There was clubbing of his
fingers. Neurologic examination was normal.
After sedating and intubating the patient, empiric anti-
biotics were initiated, and 1.6 L of serosanguinous
pleuritic fluid was aspirated. Arterial blood gases on
100% oxygen via facemask revealed a blood pH of 7.42;
PaCO2 30 mmHg; PaO2 80 mmHg; HCO3 20 mEq/L and
SaO2 97%. Urine toxicology was positive for cocaine and
opiates, while serum electrolytes, blood counts and liver
function tests were normal. Cardiac enzymes were
unremarkable, and electrocardiography showed sinus
tachycardia with left ventricular hypertrophy and left atrial
enlargement.
Radiography of the chest revealed left basilar infiltrates
and pleural density that could represent pleural effusion.
Also, there were chronic right upper lung scarring and
cystic changes. Computed Tomography of the chest and
abdomen showed extensive left basilar pleural disease
with loss of lung volume, nodular left pleural thickening
and a nodular pericardium. Nodules in the right lung were
consistent with metastatic disease (see Figure 1). The right
adrenal gland contained a necrotic mass (not shown).
Positron Emission Tomography-Computed Tomography
(PET-CT) revealed extensive left pleural thickening with
associated hypermetabolism. A greater degree of hyper-
metabolism was located in the posterior lung base, with a
density that was interpreted as pleural fluid (see Figure 2A
& B). The right adrenal mass demonstrated hypermeta-
bolic activity (see Figure 2C).
H&E stain of the left posteroinferior pleura and right
adrenal mass showed a malignant neoplasm consisting of
papillary structures, branching tubules, and gland-like
acinar and cystic spaces. These structures were lined by
uniform cuboidal and flattened epithelial-like cells with
large, round-to-oval, pleomorphic, vesicular nuclei, pro-
minent macronucleoli, occasional mitotic figures and
abundant eosinophilic cytoplasms with distinct cytoplas-
mic borders (see Figure 3A & B). Occasional mucin
droplets were present. The surrounding matrix varied from
myxoid to densely fibrous with hyalinized material with
rare mitotic figures (1/10 hpf). Based on microscopic
features, it was essential to distinguishmalignant mesothe-
lioma from pulmonary adenocarcinoma. This was
achieved by immunohistochemical analysis.
Immunohistochemical (IHC) analysis of the left poster-
oinferior pleural and right adrenal masses showed similar
immunoreactivity. Neoplastic cells were strongly positive
for cytokeratin 7, focally positive for calretinin and
cytokeratin 5/6, and negative for thyroid transcription
factor-1 (TTF-1)(see Fig. 3 C-F). This profile was consistent
with primary malignant mesothelioma of the left pleural
mass and metastatic mesothelioma of the right adrenal
mass. IHC analysis is typically used for diagnosing and
differentiating mesotheliomas from other lung cancers.
This requires the utilization of a panel of immunostains
such as TTF-1, calretinin, CK5/CK6, MOC31, B72.3,
and BG8. Anti-calretinin antibody is the most specific
Figure 1. CT scan of the chest shows extensive left basilar
pleural disease with loss of lung volume, nodular left pleural
thickening and a nodular pericardium. Nodules in the right
lung are consistent with metastatic disease.
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both cytoplasmic and nuclear distribution patterns. TTF-1
is found only in thyroid-derived tissue and lung carcino-
mas. CK5 and CK6 are strongly positive in epithelial
mesotheliomas, while pulmonary adenocarcinomas are
predominantly negative. Conversely, both lung carcinomas
andmesotheliomas are stronglyimmunoreactive with CK7.
Discussion
This 41-year old patient subsequently died due to
complications from continued mesothelioma metastases
and HIV/AIDS. The diagnosis of mesothelioma has
traditionally posed a challenge even to experienced
pathologist. This is because the epithelial-variant is
histologically similar to adenocarcinoma. They can be
effectively differentiated by IHC analysis. Undoubtedly,
our patient had epithelial-variant mesothelioma, not
adenocarcinoma, since IHC analysis confirmed the pre-
sence of calretinin, cytokeratin 5, 6 and 7, and the absence
of TTF-1 normally present in adenocarcinoma.
Etiology & Pathogenesis
The risk of developing mesothelioma may be increased by
exposure to asbestos. However, a host of other factors may
contribute to the occurrence of mesothelioma, including
cigarette smoke, infection by immunomodulatory viruses
SV-40 and HIV, and immunosenescence due to aging.
It is well documented that cigarette smoke increases the
risk of airway cancers. Individuals with a history of
smoking without asbestos exposure have an eleven-fold
Figure 2. PET-CT shows extensive pleural thickening
associated with hypermetabolism primarily in the lung base
posteriorly, with a density that suggests excess pleural fluid
(A & B). There is a large mass in the right adrenal gland that is
hypermetabolic and appears to be a tumor (C).
Figure 3. A & B: Pleural biopsy, H&E stain : There are nests,
cords, and gland-like structures present (A). Tumor cells are
composed of epithelial-like cells with eosinophilic cytoplasm,
marked nuclear pleomorphism, macronucleoli and occasional
mitotic figures (B). C&D :Immunohistochemistry: Tumor
cells are focally positive for calretinin (C) and CK5/6 (D).
E&F :Immunohistochemistry: Tumor cells are strongly
positive for CK7 (E) and negative for TTF-1 (F).
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when there is a history of asbestos exposure without
cigarette smoking, there is only a five-fold relative risk of
developing airway lung cancer. When combined, smoking
and asbestos increase the relative risk of airway lung cancer
by fifty-five folds[2]. However, evidence to support
smoking as an increased risk specifically for mesothelioma
formation is lacking. It has been shown that cigarette
smoking increases the permeability of the lungs, making it
easier for asbestos fibers to penetrate the lung parench-
yma. Also, research has demonstrated that greater con-
centrations of asbestos fibers are retained in the lungs of
smokers compared to non-smokers. Additionally, smok-
ing dysregulates the mucociliary escalator, leading to
diminished ability to clear foreign material (such as
asbestos) from the airways[3]. Studies performed in rats
showed that smoking enhances susceptibility to mesothe-
lioma in animals with a history of asbestos exposure[4].
When considered together, these reports suggest the
occurrence of enhanced mesothelioma-induction during
dual-exposure to cigarette smoke and asbestos. However,
more studies are needed.
It is possible that our patient was exposed to environ-
mental asbestos in lieu of occupational asbestos, since this
has been linked to the development of mesothelioma.
However, the question of incubation time remains a point
of conflict for this 41-year old patient, since progression to
mesothelioma generally requires 30-50 years incubation.
Interestingly, the polyoma virus SV-40 has been impli-
cated as a participant in some cases of mesothelioma. It is
postulated that since the virus inactivates anti-tumor genes
such as retinoblastoma, it promotes immunosuppression
that may lead to enhanced susceptibility to mesothelioma.
Like SV-40 virus, HIV is also an oncovirus and therefore
capable of inducing cancer. Since HIV suppresses the
immune system by depleting immune cells, and produces
neoplasms such as lymphomas in infected patients, we
believe that HIV increases the susceptible to mesothe-
lioma. Although not as prevalent in HIV-infected patients
as Kaposi’s sarcoma and non-Hodgkin’s lymphoma,
mesothelioma cases have been reported in this patient
population without a history of asbestos exposure[5;6).
Some credence to the role of immunomodulation has
been provided by the detection of immunosuppressive
mediators in pleural effusions that were located adjacent
to mesothelioma cells. For example, it has been shown
that mesothelioma cells can produce TNF-alpha, which
promotes immunodysfunction that aids in protection of
the malignant cells via NF-kB-mediated signaling[7].
Other immunosuppressed patients include transplant
patients and elderly individuals. Transplant patients are
immunosuppressed due to immunocytotoxic drugs imple-
mented to prevent transplant organ rejection, while elderly
patients undergo physiologic immunosenescence charac-
terized by reduced cellular and humoral immune
responses[8]. Not surprisingly, mesothelioma has been
reported in transplant patients, in the absence of notable
asbestos exposure[9], and mesotheliomas are classically
reported in elderly patients.
In summary, these reports suggest that compared to the
general population, mesothelioma may be more prevalent
in SV-40 virus-infected patients, HIV/AIDS patients, organ
transplant patients, and elderly patients. Even more
interesting, these reports hint at the possible role of
immunosuppression as a prerequisite for mesothelioma
occurrence.
Treatment and Prognosis
The prognosis for our patient could have been estimated
by considering his age of less than 65-years, the epithelial-
variant of mesothelioma identified, the patient’s serum
lactate dehydrogenase value less than 500 IU/L, and the
platelet counts less than 400 000/mm
3. While these
criteria suggested a favorable profile for mesothelioma
that would be slowly progressive, the Butchart system
suggested a grim prognosis since he had stage IV
mesothelioma. His prognosis was guarded and his disease
was predicted to progress to fatality in 6 to 18 months.
Treatment with pemetrexed and cisplatin may reduce the
rate of disease progression, while smoking cessation and
early intervention with supplemental oxygen for hypox-
emia may assist in symptom management. Influenza,
pneumococcal and meningococcal vaccinations were
recommended since he had increased risk for pneumonia.
Finally, anti-retroviral therapy can provide immuno-
cytoprotection that may reduce the rate of disease
progression. The patient described in this report received
all of the above treatments, however his disease was
already too advanced and rapidly progressed to death.
Conclusions
The major risk factor for the development of mesothe-
lioma is exposure to asbestos, and disease typically occurs
in elderly patients 30-50 years post-exposure. Disease
manifestation involves progressive respiratory distress and
chest pain that arise from pleural fibrosis/effusions. In
severe cases, hypertrophic pulmonary osteo-arthropathy,
Cor pulmonale and heart failure have occurred.
The development of mesothelioma in patients with HIV/
AIDS, SV-40 infection, organ transplant, or advanced age
suggests that chronic immunosuppression enhances sus-
ceptibility to mesothelioma. Since disease in many of
these patients has been documented prior to the 5
th
decade of life, it is plausible to suggest that immunosup-
pression either promotes or accelerates the development
of mesothelioma, precluding the need for 30-50 years of
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young asbestos workers may actually restrict the onset/
progression of mesothelioma, therefore leading to a
meager 8% prevalence in young asbestos workers.
Further research is needed in order to gain a better
understanding of mesothelioma pathogenesis. In an effort
to identify occupational mesothelioma earlier during
disease progression, high-risk workers can be screened
for abnormal serum osteopontin levels, since this is
routinely elevated in mesothelioma. Although serum
osteopontin may also be elevated in other forms of cancer,
Pass et al. demonstrated that serum osteopontin has a
77.7% sensitivity and 85.5% specificity for mesothelioma
[10]. Finally, we hope this report will stimulate clinicians
to consider the possibility of mesothelioma in cases where
lung cancer is coupled with immunosuppression.
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